These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14667657)

  • 1. Use of recombinant factor VIIa as a rescue treatment for intractable bleeding following repeat aortic arch repair.
    Stratmann G; Russell IA; Merrick SH
    Ann Thorac Surg; 2003 Dec; 76(6):2094-7. PubMed ID: 14667657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery.
    Končar IB; Davidović LB; Savić N; Sinđelić RB; Ilić N; Dragas M; Markovic M; Kostic D
    J Vasc Surg; 2011 Apr; 53(4):1032-7. PubMed ID: 21215579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of recombinant coagulation factor VIIa in uncontrolled postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
    Pychyńska-Pokorska M; Moll JJ; Krajewski W; Jarosik P
    Pediatr Crit Care Med; 2004 May; 5(3):246-50. PubMed ID: 15115562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic therapy for postoperative bleeding in children after cardiac surgery: when will the bleeding stop?
    Yan Q; Chang AC
    Pediatr Crit Care Med; 2004 May; 5(3):297-8. PubMed ID: 15167716
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of recombinant activated factor VII for bleeding following operations requiring cardiopulmonary bypass.
    DiDomenico RJ; Massad MG; Kpodonu J; Navarro RA; Geha AS
    Chest; 2005 May; 127(5):1828-35. PubMed ID: 15888865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective management of refractory postcardiotomy bleeding with the use of recombinant activated factor VII.
    Filsoufi F; Castillo JG; Rahmanian PB; Scurlock C; Fischer G; Adams DH
    Ann Thorac Surg; 2006 Nov; 82(5):1779-83. PubMed ID: 17062247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letter by Al-Ruzzeh and Navia regarding article, "Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery".
    Al-Ruzzeh S; Navia JL
    Circulation; 2010 Mar; 121(9):e234. PubMed ID: 20212289
    [No Abstract]   [Full Text] [Related]  

  • 8. Aortic dissection and hypothermic arrest in a Jehovah's Witness patient: a case for recombinant factor VIIa?
    Ballen J; Raabe M; Muirhead B
    Can J Anaesth; 2006 Apr; 53(4):353-6. PubMed ID: 16575032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
    Pychyńska-Pokorska M; Pągowska-Klimek I; Krajewski W; Moll JJ
    J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):987-94. PubMed ID: 21835642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invited commentary.
    Hoch JR
    J Vasc Surg; 2011 Apr; 53(4):1037-8. PubMed ID: 21439457
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of recombinant activated factor VII after axillofemoral bypass grafting.
    Cheng CA; Ho AM
    Anaesth Intensive Care; 2006 Jun; 34(3):375-8. PubMed ID: 16802495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preemptive use of recombinant activated factor VII: many questions but few answers.
    Samama CM
    Can J Anaesth; 2006 Apr; 53(4):336-8. PubMed ID: 16575029
    [No Abstract]   [Full Text] [Related]  

  • 13. Recombinant factor VIIa for refractory bleeding after cardiac surgery secondary to anticoagulation with the direct thrombin inhibitor lepirudin.
    Oh JJ; Akers WS; Lewis D; Ramaiah C; Flynn JD
    Pharmacotherapy; 2006 Apr; 26(4):569-577. PubMed ID: 16553518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recombinant activated factor VII in uncontrolled hemorrhage].
    Colomina MJ; Altisent C; Guerrero E; Godet C
    Med Clin (Barc); 2005 Feb; 124(4):156. PubMed ID: 15713248
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of recombinant activated factor VII in cardiac surgery for an effective treatment of severe intractable bleeding.
    Vanek T; Straka Z; Hrabak J; Jares M; Brucek PJ; Votava J
    Jpn Heart J; 2004 Sep; 45(5):855-60. PubMed ID: 15557726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraoperative use of low-dose recombinant activated factor VII during thoracic aortic operations.
    Andersen ND; Bhattacharya SD; Williams JB; Fosbol EL; Lockhart EL; Patel MB; Gaca JG; Welsby IJ; Hughes GC
    Ann Thorac Surg; 2012 Jun; 93(6):1921-8; discussion 1928-9. PubMed ID: 22551846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case 5-2006: recombinant factor VIIa in the management of postoperative bleeding after repair for inadvertently thrombolysed acute type A aortic dissection.
    Faber P; Reid C; El-Shafei H; Falase B; DeAnda A; Mazer CD
    J Cardiothorac Vasc Anesth; 2006 Oct; 20(5):736-41. PubMed ID: 17023299
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of refractory bleeding post-cardiopulmonary bypass in an acute heparin-induced thrombocytopenia type II renal failure patient who underwent urgent cardiac surgery with bivalirudin (Angiox
    Hassen K; Maccaroni MR; Sabry H; Mukherjee S; Serumadar S; Birdi I
    Perfusion; 2018 Apr; 33(3):235-240. PubMed ID: 28789610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Off-label use of recombinant factor VIIA concentrates after cardiac surgery.
    Despotis G; Avidan M; Lublin DM
    Ann Thorac Surg; 2005 Jul; 80(1):3-5. PubMed ID: 15975330
    [No Abstract]   [Full Text] [Related]  

  • 20. Managing uncontrolled hemorrhage in trauma and surgery: a novel and promising approach.
    Hardy JF
    Can J Anaesth; 2002 Dec; 49(10):S4-6. PubMed ID: 12545999
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.